Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 4/20 | 0.45 |
| ▸ | THRB | P10828 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | GSK3B | P49841 | 1/20 | 0.43 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | F3 | P13726 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9010520 | 0.89 | LMNA (0.46) | LMNATDP1MAPTTHRBKDM4E | |
| SCHEMBL19717830 | 0.89 | MAPT (0.48) | LMNATDP1MAPTTHRBKDM4E | |
| SCHEMBL6162547 | 0.87 | TDP1 (0.57) | LMNATDP1MAPTTHRBKDM4E | |
| Amiloxate SCHEMBL29696497 | 0.86 | LMNA (0.76) | LMNATDP1THRBKDM4EALDH1A1 | |
| SCHEMBL8375339 | 0.84 | TDP1 (0.66) | LMNATDP1MAPTTHRBKDM4E | |
| SCHEMBL30201502 | 0.83 | LMNA (0.47) | LMNATDP1MAPTTHRBKDM4E | |
| SCHEMBL489474 | 0.83 | ALOX5 (0.48) | MAPTTHRBKDM4EALDH1A1NPC1 | |
| SCHEMBL8153618 | 0.83 | NPC1 (0.59) | MAPTTHRBKDM4EALDH1A1NPC1 | |
| SCHEMBL8153624 | 0.83 | NPC1 (0.59) | MAPTTHRBKDM4EALDH1A1NPC1 | |
| SCHEMBL1716809 | 0.83 | CYP3A4 (0.54) | LMNATDP1ALDH1A1AKR1C3RECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1641 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3600224-B1 | SKIN CARE COMPOSITIONS COMPRISING A TERPOLYMER, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF | ISP INVESTMENTS LLC (US) | 2026-05-06 | — | — | EP | claimed |
| US-20260108435-A1 | SUNSCREEN COMPOSITION WITH FUNCTIONALIZED ZEOLITE SPF BOOSTERS | SAES GETTERS S.P.A. (IT) | 2026-04-23 | — | — | US | claimed |
| US-20260108436-A1 | SUNSCREEN COMPOSITION WITH SPF BOOSTERS | SAES GETTERS S.P.A. (IT) | 2026-04-23 | — | — | US | claimed |
| EP-4518849-B1 | COMPOSITION FOR TOPICAL APPLICATION FOR THE PHOTOTHERAPEUTIC TREATMENT OF INFLAMMATORY-BASED SKIN DISEASES | GIULIANI SPA (IT) | 2026-04-08 | — | — | EP | claimed |
| EP-4648735-B1 | SUNSCREEN COMPOSITION WITH SPF BOOSTERS | GETTERS SPA (IT) | 2026-03-11 | — | — | EP | claimed |
| EP-4706780-A2 | COMPOSITIONS COMPRISING UV-FILTERS AND ONE OR MORE (BIO)-ALKANEDIOLS | Symrise AG (DE) | 2026-03-11 | — | — | EP | claimed |
| EP-4061326-B1 | PERSONAL CARE COMPOSITION COMPRISING A MULTISTAGE POLYMER | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-02-25 | — | — | EP | claimed |
| EP-4648734-B1 | SUNSCREEN COMPOSITION WITH FUNCTIONALIZED ZEOLITE SPF BOOSTERS | GETTERS SPA (IT) | 2026-02-18 | — | — | EP | claimed |
| US-20260014066-A1 | Silk-Based Moisturizer Compositions and Methods Thereof | EVOLVED BY NATURE INC (US) | 2026-01-15 | — | — | US | claimed |
| EP-4251121-B1 | TOPICAL COMPOSITION | DSM IP ASSETS BV (NL) | 2025-10-01 | — | — | EP | claimed |
| EP-1324017-A2 | Method to determine realistic UV protection factors or broad spectrum indexes | Coty B.V. (NL) | 2003-07-02 | — | — | EP | claimed |
| EP-0761201-B1 | Ultraviolet radiation absorption composition | ROHM & HAAS (US) | 2002-01-09 | — | — | EP | claimed |
| WO-2001003663-A1 | SUNSCREEN FORMULATIONS | H A MILTON HOLDINGS PTY LTD (AU) | 2001-01-18 | — | — | WO | claimed |
| EP-0969004-A2 | 2,4,6-Trianilino-1,3,5-triazine derivatives, their preparation and their use as sunscreens against UV-B sun radiations | 3V SIGMA S.p.A (IT) | 2000-01-05 | — | — | EP | claimed |
| EP-0834302-A1 | Compositions comprising glutathione liposomes | Boehringer Ingelheim Limited (GB) | 1998-04-08 | — | — | EP | claimed |
| EP-0419164-B1 | Hair conditioning composition | UNILEVER PLC (GB) | 1994-11-30 | — | — | EP | claimed |
| EP-0386898-B1 | SHAMPOO COMPOSITION | UNILEVER PLC (GB) | 1993-09-01 | — | — | EP | claimed |
| US-5186928-A | Anionic surfactant, water-insoluble sunscreen, and cationic derivative of polygalactomannan gum | CHESEBROUGH-POND'S USA CO., DIVISION OF CONOPCO, INC. (US) | 1993-02-16 | — | — | US | claimed |
| EP-0419164-A1 | Hair conditioning composition | UNILEVER PLC (GB) | 1991-03-27 | — | — | EP | claimed |
| EP-0386898-A1 | Shampoo composition | UNILEVER PLC (GB) | 1990-09-12 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260108435-A1 | SUNSCREEN COMPOSITION WITH FUNCTIONALIZED ZEOLITE SPF BOOSTERS | SOD1, MCM5, GSTM1 | LMNA 819/4885TDP1 3292/4885MAPT 3109/4885 |
| US-20260014066-A1 | Silk-Based Moisturizer Compositions and Methods Thereof | CUTA, CD44, F12 | LMNA 673/4885TDP1 3906/4885MAPT 817/4885 |
| US-20260108436-A1 | SUNSCREEN COMPOSITION WITH SPF BOOSTERS | BRCA1, SQOR, NDUFB5 | LMNA 2402/4885TDP1 497/4885MAPT 3653/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.